ATE469970T1 - Plasmidvektor - Google Patents

Plasmidvektor

Info

Publication number
ATE469970T1
ATE469970T1 AT00922897T AT00922897T ATE469970T1 AT E469970 T1 ATE469970 T1 AT E469970T1 AT 00922897 T AT00922897 T AT 00922897T AT 00922897 T AT00922897 T AT 00922897T AT E469970 T1 ATE469970 T1 AT E469970T1
Authority
AT
Austria
Prior art keywords
integrase
plasmid vector
dna
segment
components
Prior art date
Application number
AT00922897T
Other languages
English (en)
Inventor
Atsushi Katsumata
Sumio Hoshi
Takeshi Ihara
Susumu Ueda
Original Assignee
Nippon Inst For Biolog Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Inst For Biolog Science filed Critical Nippon Inst For Biolog Science
Application granted granted Critical
Publication of ATE469970T1 publication Critical patent/ATE469970T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/30Bird
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
AT00922897T 1999-06-04 2000-04-27 Plasmidvektor ATE469970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15835199 1999-06-04
PCT/JP2000/002785 WO2000075342A1 (fr) 1999-06-04 2000-04-27 Nouveau vecteur plasmidique

Publications (1)

Publication Number Publication Date
ATE469970T1 true ATE469970T1 (de) 2010-06-15

Family

ID=15669764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922897T ATE469970T1 (de) 1999-06-04 2000-04-27 Plasmidvektor

Country Status (6)

Country Link
US (1) US6936465B1 (de)
EP (1) EP1103614B1 (de)
AT (1) ATE469970T1 (de)
AU (1) AU4315000A (de)
DE (1) DE60044488D1 (de)
WO (1) WO2000075342A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1319713B1 (de) * 2000-09-20 2010-01-27 Takara Bio Inc. Komplex
HRP20050237A2 (en) * 2002-08-13 2006-06-30 Kaneka Corporation Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained
WO2004080162A2 (en) * 2003-03-07 2004-09-23 Avigenics, Inc. Integrase mediated avian transgenesis
CN1961071A (zh) * 2004-03-15 2007-05-09 比奥根艾迪克Ma公司 使用可选剪接在真核细胞中表达多肽多聚体的方法和构建物
WO2006035687A1 (ja) * 2004-09-28 2006-04-06 Kaneka Corporation 遺伝子導入鳥類作製法
US7892810B2 (en) * 2006-09-15 2011-02-22 University Of Maryland, Baltimore Corynephage integrase-based site-specific insertion vector system
WO2016073559A1 (en) * 2014-11-05 2016-05-12 The Regents Of The University Of California Methods for autocatalytic genome editing and neutralizing autocatalytic genome editing

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2194488A1 (en) * 1994-08-05 1996-02-15 Tod Paul Holler Method of using transdominant negative retroviral integrase in the treatment of retroviral infection
JPH11505128A (ja) 1995-05-22 1999-05-18 カイロン コーポレイション キメラインテグラーゼタンパク質に媒介される真核生物ゲノム中へのベクター構築物の位置特異的組み込み
DE19530412A1 (de) * 1995-08-18 1997-02-20 Harald Von Prof Dr Melchner Selbst deletierende retrovirale Vektoren für die Gentherapie

Also Published As

Publication number Publication date
US6936465B1 (en) 2005-08-30
EP1103614A1 (de) 2001-05-30
DE60044488D1 (de) 2010-07-15
WO2000075342A1 (fr) 2000-12-14
AU4315000A (en) 2000-12-28
EP1103614A4 (de) 2002-02-27
EP1103614B1 (de) 2010-06-02

Similar Documents

Publication Publication Date Title
PL2169063T3 (pl) Kwas nukleinowy promotora pochodzący od bakterii z rodzaju Corynebacterium, kaseta ekspresyjna obejmująca promotor i wektor obejmujący kasetę, komórka gospodarza obejmująca wektor i sposób wyrażania genu z użyciem komórki
TWI319008B (en) Multiple inducible gene regulation system
WO2001019981A3 (en) Functional genomics using zinc finger proteins
AU4563300A (en) Regulation of viral gene expression
WO1994025612A3 (fr) Sequences de nucleotides pour le controle de l'expression de sequences d'adn dans un hote cellulaire
CA2398473A1 (en) Multi zone cracking furnace
DK0939763T3 (da) Styret skift-medieret DNA-rekombination
AU3372799A (en) Methods for exogenous, internal controls during nucleic acid amplification
EP1471926B8 (de) Zusammensetzungen und verfahren zur therapeutischen anwendung einer mit dem gen atonal assoziierten sequenz
DE60044488D1 (de) Plasmidvektor
EP1120461A4 (de) Verfahren zur herstellung von copolymerisierten polyestern
ATE342998T1 (de) Replikation -defektive baculoviren expressionssystem
AU2002361951A1 (en) Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins
WO2000058352A3 (en) Barley gene for thioredoxin and nadp-thioredoxin reductase
AU689803B2 (en) Plant-derived phospholipase D gene
AU4903099A (en) Targeted integration into chromosomes using retroviral vectors
WO2000061729A3 (en) Regulation of the expression of transcriptional repressor genes using nucleic acid molecules
WO2001053474A3 (en) Flavobacterium heparinum expression system
CA2058971A1 (en) Efficient method for identifiable expression of non-selectable genes
AU2003278603A1 (en) Hm1.24-utilizing cancer vaccines
AU2003241686A1 (en) Chondroitin synthetase and nucleic acid coding for the enzyme
DE69938427D1 (de) Tes gen und dessen verwendung
AU2002322911A1 (en) Use of alphacp1, alphacp2, and hur for modulating gene expression and inducing angiogenesis
DE60036134D1 (de) Methoden und materialien fur genexpression
WO2002000897A3 (en) Novel chimeric promoters

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties